ATE267204T1 - Verfahren zur herstellung von substituierten pyridinen - Google Patents

Verfahren zur herstellung von substituierten pyridinen

Info

Publication number
ATE267204T1
ATE267204T1 AT01302635T AT01302635T ATE267204T1 AT E267204 T1 ATE267204 T1 AT E267204T1 AT 01302635 T AT01302635 T AT 01302635T AT 01302635 T AT01302635 T AT 01302635T AT E267204 T1 ATE267204 T1 AT E267204T1
Authority
AT
Austria
Prior art keywords
substituted pyridines
producing substituted
producing
pyridines
substituted
Prior art date
Application number
AT01302635T
Other languages
English (en)
Inventor
Robert Lee Dow
Steven Roy Schneider
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE267204T1 publication Critical patent/ATE267204T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/188Preparation; Treatments not provided for in C07F7/20 by reactions involving the formation of Si-O linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT01302635T 2000-03-31 2001-03-21 Verfahren zur herstellung von substituierten pyridinen ATE267204T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19377200P 2000-03-31 2000-03-31

Publications (1)

Publication Number Publication Date
ATE267204T1 true ATE267204T1 (de) 2004-06-15

Family

ID=22714938

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01302635T ATE267204T1 (de) 2000-03-31 2001-03-21 Verfahren zur herstellung von substituierten pyridinen

Country Status (25)

Country Link
US (4) US6518431B2 (de)
EP (1) EP1138685B1 (de)
JP (1) JP2001316393A (de)
KR (2) KR100435128B1 (de)
CN (1) CN1191235C (de)
AR (1) AR033812A1 (de)
AT (1) ATE267204T1 (de)
AU (1) AU782272B2 (de)
BR (1) BR0101280A (de)
CA (1) CA2342571A1 (de)
CZ (1) CZ20011194A3 (de)
DE (1) DE60103317T2 (de)
DK (1) DK1138685T3 (de)
ES (1) ES2217090T3 (de)
HU (1) HUP0101332A3 (de)
ID (1) ID29728A (de)
MX (1) MXPA01003383A (de)
PL (1) PL346805A1 (de)
PT (1) PT1138685E (de)
RU (1) RU2223956C2 (de)
SI (1) SI1138685T1 (de)
TR (1) TR200401359T4 (de)
TW (1) TW555761B (de)
YU (1) YU23301A (de)
ZA (1) ZA200102538B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102037602B1 (ko) 2018-04-20 2019-10-28 사단법인 한국지능형교통체계협회 저상 버스용 고정 바를 갖춘 휠체어 잠금장치
KR20190122333A (ko) 2018-04-20 2019-10-30 사단법인 한국지능형교통체계협회 스터드 레일 피팅

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559256A (en) * 1992-07-20 1996-09-24 E. R. Squibb & Sons, Inc. Aminediol protease inhibitors
US5705515A (en) * 1994-04-26 1998-01-06 Merck & Co., Inc. Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
WO1997046556A1 (en) * 1996-06-07 1997-12-11 Merck & Co., Inc. OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY
US5792871A (en) 1996-07-22 1998-08-11 Merck & Co., Inc. Process for N-Boc-N-(R)-2(3-pyridyl)-2-hydroxy-ethyl)-N-2(4-aminophenyl)ethyl amine and 2-(4-aminophenyl)-N-2-(2(R)-hydroxy-2-phyridin-S-yl-ethyl)acetamide
ID22273A (id) * 1997-01-28 1999-09-23 Merck & Co Inc TIAZOL BENZENASULFONAMIDA SEBAGAI AGONIS β UNTUK PENGOBATAN DIABETES DAN OBESITAS
AU2571300A (en) * 1999-02-16 2000-09-04 Kaneka Corporation Substituted acetylpyridine derivatives and process for the preparation of intermediates for optically active beta3 agonist by the use of the same

Also Published As

Publication number Publication date
EP1138685A2 (de) 2001-10-04
DK1138685T3 (da) 2004-08-09
ZA200102538B (en) 2002-09-30
HUP0101332A3 (en) 2004-07-28
US6670480B2 (en) 2003-12-30
HUP0101332A2 (en) 2002-10-28
ES2217090T3 (es) 2004-11-01
US6844441B2 (en) 2005-01-18
CA2342571A1 (en) 2001-09-30
DE60103317T2 (de) 2005-06-16
HK1038019A1 (en) 2002-03-01
RU2223956C2 (ru) 2004-02-20
TW555761B (en) 2003-10-01
EP1138685B1 (de) 2004-05-19
HU0101332D0 (en) 2001-06-28
US20050113578A1 (en) 2005-05-26
TR200401359T4 (tr) 2004-08-23
EP1138685A3 (de) 2003-04-02
KR100481603B1 (ko) 2005-04-08
PL346805A1 (en) 2001-10-08
PT1138685E (pt) 2004-08-31
SI1138685T1 (en) 2004-12-31
JP2001316393A (ja) 2001-11-13
ID29728A (id) 2001-10-04
KR20030072295A (ko) 2003-09-13
YU23301A (sh) 2003-04-30
CZ20011194A3 (cs) 2002-02-13
US20030114670A1 (en) 2003-06-19
DE60103317D1 (de) 2004-06-24
US20020077478A1 (en) 2002-06-20
MXPA01003383A (es) 2005-08-26
BR0101280A (pt) 2001-11-06
CN1320596A (zh) 2001-11-07
US6518431B2 (en) 2003-02-11
AU782272B2 (en) 2005-07-14
US20040133005A1 (en) 2004-07-08
KR100435128B1 (ko) 2004-06-09
AR033812A1 (es) 2004-01-07
AU3334801A (en) 2001-12-13
CN1191235C (zh) 2005-03-02
KR20010095192A (ko) 2001-11-03

Similar Documents

Publication Publication Date Title
ATE386736T1 (de) Verfahren zur herstellung von benzimidazol-2-yl - chinolinonderivaten
DE60107450D1 (de) Verfahren zur herstellung von fluoroelastomeren
DE60221399D1 (de) Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de) Verfahren zur herstellung von o- desmethylvenlafaxin
AT7110U9 (de) Verfahren zur herstellung von amlodipinmaleat
DE60230908D1 (de) Verfahren zur herstellung von polyarylenethern
ATE331804T1 (de) Verfahren zur herstellung von ansamitocin
DE60003264D1 (de) Verfahren zur herstellung von glycerylethern
ATE281429T1 (de) Verfahren zur herstellung von substituierten phenylacetonitrilen
DE50102444D1 (de) Verfahren zur herstellung von isocyanatoorganosilanen
ATE316518T1 (de) Verfahren zur herstellung von (r)-2-alkyl-3- phenyl-1-propanolen
ATE266004T1 (de) Verfahren zur herstellung von 3-amino-2-chlor-4- methylpyridin
DE50111560D1 (de) Verfahren zur herstellung von guerbetalkoholen
ATE441662T1 (de) Verfahren zur herstellung von echinocandinderivaten
DE50006772D1 (de) Verfahren zur herstellung von oxindolen
ATE234269T1 (de) Verfahren zur herstellung von cis-1-2-(4-(6-
DE50200870D1 (de) Verfahren zur herstellung von hydroxyalkylpolysiloxanen
DE60105991D1 (de) Verfahren zur herstellung von 6-aminocapronamid
EP1208106A4 (de) Verfahren zur herstellung von aminopropyl- oder aminoalkyl-unktionalisierten polyalkyl- oder aryl-siloxanen
ATE232845T1 (de) Verfahren zur herstellung von cyclopropenen
DE50001895D1 (de) Verfahren zur herstellung von phosphonomethylglycin
ATE325810T1 (de) Verfahren zur herstellung von acetylamidiniophenylalanyl-cyclohexylglycyl- pyridylalaninamiden
ATE280760T1 (de) Verfahren zur herstellung von chinolinderivaten
ATE327995T1 (de) Verfahren zur herstellung von camptothectin
ATE233238T1 (de) Verfahren zur herstellung von 3-acyl-indolen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1138685

Country of ref document: EP

REN Ceased due to non-payment of the annual fee